Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Business > Outsourcing > Outsourcing of American Corporations; The Real Problem Causing It

Tags

  • challenges
  • manufacturing
  • advantages
  • developing combination

  • Links

  • The Different Type of Mortgages and Remortgages Available
  • Ox Chinese Zodiac: Fun Trivia
  • The Vibration Of Truth
  • Main Subject - Outsourcing of American Corporations; The Real Problem Causing It

    As many Americans complain that our Corporations are moving all
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    their manufacturing to other nations and taking all those jobs
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    with them, one has to wonder why is all this happening in the
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    irst place?

    Well imagine if you will that you are a corporatio
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    n and you are constantly being bombarded with class-action BS l
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    wsuits. Imagine the unending over regulation from all the vario
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    us agencies from the SEC on down?

    Imagine the costs you have t
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    o pay to comply with all this. Next imagine that if you moved y
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ur company offshore you could eliminate 75% of that nussiance,
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    pay lower taxes and increase profits?

    Would you choose to offs
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ore? Well that is exactly what the shareholders want; increased
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    profits, quarterly increases and increased valuation because o
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    f it right? Indeed, now you are beginning to understand why the
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    off-shoring and outsourcing is occurring.

    Next consider that y
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ou foreign competitors who sell in the USA no longer have an ad
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    antage over you in the market place, because now you too are a
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    foreign corporation or a division of one. After all this you al
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    so see you have much lower labor costs, no Union demands and yo
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    can still sell to the US Middle Class? Wow, bonus indeed, so w
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    hy on Earth wouldn’t you outsource? Hmmm? Consider this in 2006


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/32885/mainsubjects-Outsourcing-of-American-Corporations-The-Real-Problem-Causing-It.html">Outsourcing of American Corporations; The Real Problem Causing It</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/32885/mainsubjects-Outsourcing-of-American-Corporations-The-Real-Problem-Causing-It.html]Outsourcing of American Corporations; The Real Problem Causing It[/url]

    Related Articles:

    Brand Image - Brand Identity - Brand Strategy - Brand Identity Guru

    Job Interview - 5 Ways To Improve Your Communication Skills

    1000 Managers Turned Their Plans Into Energy!

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com